Jose A. Todoli

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2.

OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2.

Journal: iScience

Published: July 22, 2024

Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.

Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.

Journal: JAMA network open

Published: April 07, 2023

Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency.

Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: August 04, 2021

Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.

Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.

Journal: Orbit (Amsterdam, Netherlands)

Published: February 09, 2018

First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.

First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.

Journal: Clinical rheumatology

Published: July 14, 2017

Is erythrocyte sedimentation rate a useful inflammatory marker independently of the hematocrit? Comparison results with plasma viscosity.

Is erythrocyte sedimentation rate a useful inflammatory marker independently of the hematocrit? Comparison results with plasma viscosity.

Journal: Clinical hemorheology and microcirculation

Published: August 28, 2014

Increased circulating endothelial cells and microparticles in patients with psoriasis.

Increased circulating endothelial cells and microparticles in patients with psoriasis.

Journal: Clinical hemorheology and microcirculation

Published: September 05, 2013

Haematological, biochemical and inflammatory parameters in inactive Behçet's disease. Its association with red blood cell distribution width.

Haematological, biochemical and inflammatory parameters in inactive Behçet's disease. Its association with red blood cell distribution width.

Journal: Clinical hemorheology and microcirculation

Published: May 31, 2013

Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy.

Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy.

Journal: Clinical hemorheology and microcirculation

Published: April 24, 2013

Homocysteine levels in patients with primary and secondary Raynaud's phenomenon. Its association with microangiopathy severity.

Homocysteine levels in patients with primary and secondary Raynaud's phenomenon. Its association with microangiopathy severity.

Journal: Clinical hemorheology and microcirculation

Published: February 21, 2013

Psoriasis and hemorheology. Influence of the metabolic syndrome.

Psoriasis and hemorheology. Influence of the metabolic syndrome.

Journal: Clinical hemorheology and microcirculation

Published: October 24, 2012

Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behçet's disease.

Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behçet's disease.

Journal: Clinical hemorheology and microcirculation

Published: July 04, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026